Featured Image
Why is it important?
As budgets are tightened, innovative approaches are required to capture value for buyers and sellers to ensure patients have access to needed medicines.
Perspectives
Capturing perspectives on product listing agreements from Canadian and International voices provides unique insight into the increasingly competitive pharmaceutical market place.
Mr. Steve Long
Global Public Affairs
Read the Original
This page is a summary of: Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders, ClinicoEconomics and Outcomes Research, August 2016, Dove Medical Press,
DOI: 10.2147/ceor.s96616.
You can read the full text:
Contributors
The following have contributed to this page
